ALIM Alimera Sciences Inc

USD 3.37 0.00 0
Icon

Alimera Sciences Inc (ALIM) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.37

0.00 (0.00)%

USD 0.18B

0.09M

N/A

N/A

Icon

ALIM

Alimera Sciences Inc (USD)
COMMON STOCK | NSD
USD 3.37
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.18B

N/A

USD 3.37

Alimera Sciences Inc (ALIM) Stock Forecast

N/A

Based on the Alimera Sciences Inc stock forecast from 0 analysts, the average analyst target price for Alimera Sciences Inc is not available over the next 12 months. Alimera Sciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alimera Sciences Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Alimera Sciences Inc’s stock price was USD 3.37. Alimera Sciences Inc’s stock price has changed by -1.46% over the past week, -14.68% over the past month and +49.45% over the last year.

No recent analyst target price found for Alimera Sciences Inc
No recent average analyst rating found for Alimera Sciences Inc

Company Overview Alimera Sciences Inc

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabe...Read More

https://alimerasciences.com

6310 Town Square, Alpharetta, GA, United States, 30005

150

December

USD

USA

Adjusted Closing Price for Alimera Sciences Inc (ALIM)

Loading...

Unadjusted Closing Price for Alimera Sciences Inc (ALIM)

Loading...

Share Trading Volume for Alimera Sciences Inc Shares

Loading...

Compare Performance of Alimera Sciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ALIM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alimera Sciences Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NBIX
Neurocrine Biosciences Inc 0.00 (0.00%) USD11.45B 61.66 38.67

ETFs Containing ALIM

Symbol Name ALIM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alimera Sciences Inc (ALIM) Stock

Stock Target Advisor's fundamental analysis for Alimera Sciences Inc's stock is Bearish.

Unfortunately we do not have enough data on ALIM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ALIM's stock to indicate what its average analyst target is.

ALIM stock's Price/Earning ratio is 12.81. Our analysis grades ALIM stock's Price / Earning ratio at F. This means that ALIM stock's Price/Earning ratio is above 46% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this ALIM may be fairly valued for its sector

The last closing price of ALIM's stock was USD 3.37.

The most recent market capitalization for ALIM is USD 0.18B.

Unfortunately we do not have enough analyst data on ALIM's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Alimera Sciences Inc's stock.

As per our most recent records Alimera Sciences Inc has 150 Employees.

Alimera Sciences Inc's registered address is 6310 Town Square, Alpharetta, GA, United States, 30005. You can get more information about it from Alimera Sciences Inc's website at https://alimerasciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...